Study on the benefits and risks of empirical carbapenem-resistant bacterial treatment in severe pneumonia patients based on real-world decision-making: an observational cohort study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 5baec7a0253ad5f62cf6432d136c696dec879210
First added on: Oct 10, 2026